FCL

Fineotex Chemical Financial Results

₹57.80-2.36%
Market cap
₹6,731 crore
P/E
55.0
P/B
3.20
ROE
16.4%
Dividend yield
0.09%

For the year ended Mar 2019, Fineotex Chemical reported revenue of ₹182 crore and net profit of ₹24 crore, against ₹196 crore and ₹14 crore a year earlier.

Fineotex Chemical annual profit and loss

Financial years, newest first. TTM = trailing twelve months.

Fineotex Chemical annual profit and loss (₹ crore)
ItemMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue1821962193685165685327711,012
Expenses148162178297403419404634843
Operating profit35344171113149128137169
Operating margin %19%17%19%19%22%26%24%18%17%
Other income1-10176615233034
Interest111100011
Depreciation11134691315
Profit before tax34225673115158141153186
Tax %28%35%20%22%22%23%23%18%20%
Net profit2414455790121109125148
EPS (₹)2.031.183.854.987.9710.829.440.931.05
Dividend payout %—————————

Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.

Fineotex Chemical financial results — frequently asked questions

What is Fineotex Chemical's annual revenue and net profit?

For the financial year ended Mar 2019, Fineotex Chemical's revenue was ₹182 crore and net profit ₹24 crore; net profit rose 71.43% from ₹14 crore in Mar 2020.

How fast has Fineotex Chemical grown over three years?

From Mar 2022 to Mar 2019, Fineotex Chemical's revenue grew at a compound annual rate of -20.9% and net profit at -25.0%. Past growth does not indicate future results.

What is the EPS of Fineotex Chemical?

Annual EPS for Mar 2019 was ₹2.03.

Are these figures consolidated or standalone?

They are consolidated figures as reported by the company, in ₹ crore. Trailing-twelve-month and half-year columns are labelled separately and are not counted as financial years.

Same Data For Peers

Trade Fineotex Chemical With ATS

Track FCL live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.